FDA Inspection
OpAns, LLCOpAns, LLC – FDA Inspection, Jan 24, 2024
Record Details
This FDA Inspection record concerns OpAns, LLC, with an inspection on January 24, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Betsy C. Galliher (Issuing Officer)
- Hasan A. Irier (Issuing Officer)
- Mei Ou (Issuing Officer)
View Company Profile
ID · ba87504e-ad51-4226-8c87-67c0d337ef87
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1230774
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of OpAns, LLC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| January 24, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 16, 2019 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 3, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 18, 2008 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for OpAns, LLC
- FDA Inspection 1125999 - 2020-01-24
- FDA Inspection 1102873 - 2019-08-16
- FDA Inspection 937288 - 2015-08-03
- FDA Inspection 547289 - 2008-11-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.